文献速递MDS 与骨髓增殖性肿瘤

携带钙网蛋白突变的人诱导多能干细胞来源造血祖细胞中巨核细胞生成偏斜

Skewed megakaryopoiesis in human induced pluripotent stem cell-derived haematopoietic progenitor cells harbouring calreticulin mutations.
PubMed 文献 · Br J Haematol · 2018-05-09

研究从携带CALR-Ins5突变的原发性血小板增多症患者及健康人诱导多能干细胞,发现Ins5造血祖细胞巨核细胞生成更显著且GATA1、GATA2表达升高,3-羟基阿那格雷可显著干扰巨核细胞生成但不影响红细胞生成。

要点

  • 携带CALR-Ins5突变的造血祖细胞巨核细胞生成较野生型更显著。
  • Ins5造血祖细胞中GATA1和GATA2表达水平升高。
  • 3-羟基阿那格雷显著干扰巨核细胞生成,但不影响红细胞生成。

核心结论

  • 研究建立了可重现突变CALR所致巨核细胞生成的体外模型,可用于验证CALR突变MPN患者的治疗化合物及研究突变CALR在人类血液细胞分化中的作用。

研究设计与样本

  • 研究从携带CALR-Ins5突变的原发性血小板增多症患者及健康个体分别建立诱导多能干细胞,并比较其来源造血祖细胞的巨核细胞生成。

主要发现

  • Ins5造血祖细胞的巨核细胞生成较野生型造血祖细胞更显著,提示系统重现了CALR突变ET患者骨髓中观察到的巨核细胞增多。
  • Ins5造血祖细胞中GATA1和GATA2表达水平升高,提示祖细胞向巨核细胞分化的提前定向。
  • 3-羟基阿那格雷显著干扰巨核细胞生成,但不影响红细胞生成。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Somatic mutations in the calreticulin (CALR) gene have been found in most patients with JAK2- and MPL-unmutated Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs). It has recently been shown that mutant CALR constitutively activates the thrombopoietin receptor MPL and, thus, plays a causal role in the development of MPNs. However, the roles of mutant CALR in human haematopoietic cell differentiation remain predominantly elusive. To examine the impact of the 5-base insertion mutant CALR gene (Ins5) on haematopoietic cell differentiation, we generated induced pluripotent stem cells from an essential thrombocythaemia (ET) patient harbouring a CALR-Ins5 mutation and from a healthy individual (WT). Megakaryopoiesis was more prominent in Ins5-haematopoietic progenitor cells (Ins5-HPCs) than in WT-HPCs, implying that the system recapitulates megakaryocytosis observed in the bone marrow of CALR-mutant ET patients. Ins5-HPCs exhibited elevated expression levels of GATA1 and GATA2, suggesting a premature commitment to megakaryocytic differentiation in progenitor cells. We also demonstrated that 3-hydroxy anagrelide markedly perturbed megakaryopoiesis, but not erythropoiesis. Collectively, we established an in vitro model system that recapitulates megakaryopoiesis caused by mutant CALR. This system can be used to validate therapeutic compounds for MPN patients harbouring CALR mutations and in detailed studies on mutant CALR in human haematological cell differentiation.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Takei H, Edahiro Y, Mano S, et al. Skewed megakaryopoiesis in human induced pluripotent stem cell-derived haematopoietic progenitor cells harbouring calreticulin mutations. Br J Haematol. 2018. PMID: 29741776. doi:10.1111/bjh.15266

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。